Barigen 4 mg (Baricitinib)

Coadministration of a Caboxen capsule formulation with a strong CYP3A4 inhibitor increased the exposure of Caboxen, which may increase the risk of exposure-related adverse reactions.

https://iebpharma.com/product/caboxen-20mg-cabozantinib #caboxen20mg #cabozantinib #anticancer #antiviral #breastcancer #oncology #livercancer #alopecia #hepatitisc

BRIGANIX is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib.

https://iebpharma.com/product/briganix-90mg-brigatinib #briganix90mg #brigatinib #anticancer #antiviral #breastcancer #oncology #livercancer #alopecia #hepatitisc

The recommended dosage of Cabozantinib is 60 mg once daily without food until the patient no longer experiences clinical benefit or experiences unacceptable toxicity.

Enzalunix is a hormonal therapy which is indicated for metastatic castration-sensitive prostate cancer (mCSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC).

https://iebpharma.com/product/enzalunix-40mg-enzalutamide #enzalunix40mg #enzalutamide #anticancer #antiviral #breastcancer #oncology #livercancer #alopecia #hepatitisc

Pazonix is a multiple Tyrosine Kinase Inhibitor (TKI) and it is indicated for the treatment of Renal Cell Carcinoma (RCC) effectively.

https://iebpharma.com/product/pazonix-200mg-pazopanib #pazonix200mg #pazopanib #anticancer #antiviral #breastcancer #oncology #livercancer #alopecia #hepatitisc

Ivosidenib is also used to treat AML in adults 75 years and older who have newly-diagnosed AML and cannot use certain chemotherapy treatments because of other health problems.

https://iebpharma.com/product/ivosidenib-250mg-ivosenib-60-tablets #ivosidenib250mg #ivosenib #anticancer #antiviral #breastcancer #oncology #livercancer #alopecia #hepatitisc